Kintara Therapeutics, Inc.

NasdaqCM:KTRA Stock Report

Market Cap: US$12.8m

This company is no longer active

The company may no longer be operating, as it may be out of business. Find out why through their latest events.

Kintara Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of KTRA?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders68,5120.123%
Institutions806,6661.45%
General Public54,785,40098.4%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 3087.1%.

Top Shareholders

Top 22 shareholders own 1.59% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
0.62%
Geode Capital Management, LLC
343,912US$79.1k697%no data
0.2%
Susquehanna International Group, LLP, Asset Management Arm
109,255US$25.1k8.4%no data
0.14%
UBS Asset Management AG
75,822US$17.4k-45.3%no data
0.13%
XTX Holdings Limited, Asset Management Arm
74,115US$17.0k0%no data
0.12%
Robert Hoffman
64,900US$14.9k1,990%no data
0.086%
Jane Street Group, LLC, Asset Management Arm
47,874US$11.0k-31%no data
0.08%
Level Four Advisory Services, LLC, Asset Management Arm
44,642US$10.3k0%no data
0.077%
Baader Bank AG, Asset Management Arm
42,670US$9.8k0%no data
0.049%
Clear Creek Financial Management, LLC
27,500US$6.3k0%no data
0.04%
Integrated Wealth Concepts LLC
22,000US$5.1k0%no data
0.022%
The Vanguard Group, Inc.
12,455US$2.9k0%no data
0.019%
State Street Global Advisors, Inc.
10,721US$2.5k0%no data
0.005%
Dennis Brown
2,776US$638.50%no data
0.0049%
Qube Research & Technologies Ltd
2,700US$620.6-59.1%no data
0.0041%
Bank of America Corporation, Asset Management Arm
2,268US$520.80%no data
0.0031%
Tower Research Capital Europe Limited
1,733US$398.0-90.5%no data
0.0019%
Osaic Wealth, Inc. , Asset Management Arm
1,029US$236.78.43%no data
0.0013%
Scott Praill
744US$171.50%no data
0.00063%
Acadian Asset Management LLC
350US$80.60%no data
0.00011%
Laura Johnson
60US$14.10%no data
0.00006%
Robert Toth
32US$7.70%no data
0.00004%
Strategic Advisers LLC
20US$5.10%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/10/17 18:23
End of Day Share Price 2024/10/17 00:00
Earnings2024/06/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Kintara Therapeutics, Inc. is covered by 5 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Nathan WeinsteinAegis Capital Corporation
Robert WassermanDawson James Securities
Jason McCarthyMaxim Group